Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair F
Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair Dib, Taylor, Diethrich Stem Cell Therapy & Tissue Engineering for Cardiovascular Repair serves as an essential reference material covering these emerging technologies in cardiovascul
- PDF / 5,152,518 Bytes
- 332 Pages / 441 x 666 pts Page_size
- 22 Downloads / 209 Views
Nabil Dib, MD Doris A. Taylor, PhD Edward B. Diethrich, MD (Editors)
Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair From Basic Research to Clinical Applications
With 91 Illustrations, 64 in Full Color
Nabil Dib, MD, MSc, FACC Director of Cardiovascular Research Arizona Heart Institute 2632 North 20th Street Phoenix, AZ 85006 USA
Doris A. Taylor, PhD Director Center for Cardiovascular Repair University of Minnesota Minneapolis, MN USA
Edward B. Diethrich, MD Medical Director Arizona Heart Institute 2632 North 20th Street Phoenix, AZ 85006 USA
Library of Congress Control Number: 2005924728 ISBN-10: 0-387-25788-8 ISBN-13: 978-0387-25788-4
Printed on acid-free paper.
© 2006 Springer Science+Business Media, Inc. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, Inc., 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed in Singapore. 9 8 7 6 5 4 3 2 1 springeronline.com
(SPI/KYO)
Contributors
PETER ALTMAN, PH.D. President BioCardia Inc. San Francisco, California ELLEN AREMAN, M.S. Biologist United States Food and Drug Administration Center for Biologics Evaluation and Research Office of Cellular, Tissue and Gene Therapies Division of Cellular and Gene Therapies Cell Therapies Branch Rockville, Maryland FRANCISCO F. AVILESES, M.D., PH.D. Professor of Cardiology School of Medicine University of Valladolid Valladolid, Spain KIMBERLY A. BENTON, PH.D. Chief, Cell Therapies Branch United States Food and Drug Administration Center for Biologics Evaluation and Research Office of Cellular, Tissue and Gene Therapies Division of Cellular and Gene Therapies Rockville, Maryland RAVI K. BIRLA, PH.D. Research Investigator Section of Cardiac Surgery University of Michigan Ann Arbor, Michigan v
vi
Contributors
MICHAEL BREHM, M.D. Heinrich Heine University Düsseldorf, Germany DANIEL BURKHOFF, M.D., PH.D. Adjunct Associate Professor of Medicine Division of Cardiology Columbia University New York, New York BLASÉ A. CARABELLO, M.D. Professor of Medicine Vice Chairman, Department of Medicine Baylor College of Medicine Michael E. DeBakey Veterans
Data Loading...
